Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review
Cytomegalovirus (CMV), like other herpesviruses, has the unique ability to establish latent infection with subsequent reactivation during periods of stress and immunosuppression. Herpesviruses cause potentially devastating disease, particularly in hematopoietic stem cell transplant (HSCT) recipients...
Saved in:
Main Authors: | Lisa Hiskey (Author), Theresa Madigan (Author), Elizabeth H. Ristagno (Author), Raymund R. Razonable (Author), Asmaa Ferdjallah (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
by: Razonable RR
Published: (2024) -
What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis
by: Fucile C, et al.
Published: (2018) -
Rapid Resolution of Life-Threatening Hypertriglyceridemia after Evinacumab Administration in a Pediatric HSCT Recipient: A Case Report
by: Alice Fachin, et al.
Published: (2023) -
Case Report: Approaches for managing resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplantation recipients
by: Eunkyung Song, et al.
Published: (2024) -
Cytomegalovirus Infection in Pediatric Renal Transplant Recipients: A Single Center Experience
by: Mi Jin Kim, et al.
Published: (2017)